Westminster Health Forum

We are continuing to organise full-scale virtual conferences which retain all the features of physical seminars, including full programmes, presentations with slides, panel discussions and live delegate questions and comments sessions, person-to-person and group networking, and a permanent record provided to all delegates afterwards. New events are coming on to our conference programme all the time, so there are plenty of opportunities to join us if you haven’t already, from wherever you are.
For booking-related queries or information on speaking please email us at info@forumsupport.co.uk, or call +44 (0)1344 864796.

If you’re already booked on, joining instructions can be accessed from five working days before your conference via the booking dashboard. Need help? You can contact our Delegate Relations team at delegate.relations@forumsupport.co.uk or by calling the above number.

Tackling antimicrobial resistance in the UK and the UK’s role on the global stage

Morning, Wednesday, 1st December 2021


***Full-scale policy conference taking place online***

This conference will examine priorities for tackling AMR, including progress on the UK’s five-year action plan, the impact of COVID-19 on global health systems, and the potential for harnessing new networks and opportunities for collaboration to drive forward progress.


Key areas for discussion include:

  • priorities for combatting antimicrobial resistance domestically
  • the outlook for international collaboration
  • driving innovation and research and using shared expertise to develop new antibiotics
  • improving engagement with clinicians and patients to encourage the safe use of antibiotics
  • optimising the use of antimicrobials, surveillance, and infection prevention

The conference takes place following:

  • the UK Government’s priorities as presented to the UN for tackling ‘the silent pandemic of antimicrobial resistance’, including:
    • improving the way antibiotics are used
    • developing new antibiotics and supply chain safety - including via global standards
  • G7 health ministers identifying antimicrobial resistance as a key area for strategic action at their recent meeting for the G7 Summit
  • the UK’s five-year action plan for AMR, which outlines the priorities for achieving the UK’s 2040 vision for the containment and control of AMR

Attendees

Our forums are known for attracting strong interest from policymakers and stakeholders. Places have been reserved by officials from Defra; the Department for International Trade; the Department of Health and Social Care; the Food Standards Agency; the Medicines and Healthcare products Regulatory Agency; the Office for Life Sciences; The Scottish Government; and the Welsh Government. Also due to attend are representatives from bioMerieux; Camberley Alzheimer Cafe; Dunbia; LumiraDx; Medicines Discovery Catapult; Menter a Busnes; Mid Yorkshire Hospitals NHS Trust; NovaBiotics; Organic Milk Suppliers Co-operative; Robert Gordon University; Sandoz; Shionogi BV; Thermo Fisher Scientific; and Werfen UK.


Press passes have been reserved by representatives from the APM Health Europe; Complete Nutrition; and Politico.


Overall, we expect speakers and attendees to be a senior and informed group including Members of both Houses of Parliament, and senior government officials involved in this area of public policy, together with regulators, pharmaceutical and diagnostics companies, representatives from the NHS, executive agencies including clinical staff, pharmacists, local health systems, the independent and third sectors, patients groups, law firms, consultancies, and others affected by the issues discussed as well as academics and think tanks, and reporters from the national and specialist media.


This is a full-scale conference taking place online***

  • full, four-hour programme including comfort breaks - you’ll also get a full recording and transcript to refer back to
  • information-rich discussion involving key policymakers and stakeholders
  • conference materials provided in advance, including speaker biographies
  • speakers presenting via webcam, accompanied by slides if they wish, using the Cisco WebEx professional online conference platform (easy for delegates - we’ll provide full details)
  • opportunities for live delegate questions and comments with all speakers
  • a recording of the addresses, all slides cleared by speakers, and further materials, is made available to all delegates afterwards as a permanent record of the proceedings
  • delegates are able to add their own written comments and articles following the conference, to be distributed to all attendees and more widely
  • networking too - there will be opportunities for delegates to e-meet and interact - we’ll tell you how!

Full information and guidance on how to take part will be sent to delegates before the conference



Keynote Speaker

Dr Haileyesus Getahun

Director, Global Coordination and Partnership and Tripartite Joint Secretariat on AMR, World Health Organisation

Keynote Speakers

Professor Alison Holmes

Professor of Infectious Diseases, Imperial College London; Director, Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, NIHR; and Director, Centre for Antimicrobial Optimisation

Dr Colin Brown

Interim Deputy Director, Healthcare-associated Infections and Antimicrobial Resistance, Public Health England

Dr Phil Packer

Innovation Lead, AMR and Vaccines, Innovate UK

Dr Henry Skinner

Chief Executive Officer, AMR Action Fund

Dr Haileyesus Getahun

Director, Global Coordination and Partnership and Tripartite Joint Secretariat on AMR, World Health Organisation

Professor Dame Sally Davies

UK Special Envoy on AMR for UK Government and lately Chief Medical Officer for England

Chairs

Kevin Hollinrake MP

Co-Chair, All-Party Parliamentary Group on Antibiotics

Professor the Lord Trees

Emeritus Professor, University of Liverpool; and Treasurer, All-Party Parliamentary Group on Antibiotics

Speakers

Dr Stephen Oakeshott

Head of Infections and Immunity, UKRI Medical Research Council

Dr Chrysi Sergaki

Interim Head of the Microbiome Section, Division of Bacteriology, National Institute for Biological Standards and Control, MHRA

Dr Ron Daniels

Chief Executive Officer, Sepsis Trust

Dr Daniel Berman

Director, Global Health and Disability, NESTA